An in silico study proved that quercetin (6), hispidulin (3), and cirsimaritin (57) exhibited better potential inhibition than hydroxy-chloroquine potential inhibition against the COVID-19 main protease active site and ACE2 (Omar et al., 2020). The gene discussed is ACE2; the disease is COVID-19.